Disc Medicine IRON Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$63.5M-86.3% | -$60.53M-105% | -$62.32M-134% | -$55.25M-110% | -$34.09M-26.5% | ||
| $89K+345% | $89K+889% | $87K+691% | $85K-22.7% | $20K-23.1% | ||
| $11.95M+87.7% | $10.04M+132% | $9.51M+120% | $8.42M+106% | $6.36M+56.8% | ||
| $2.74M+315% | $1.75M— | $918K+188% | -$321K+52.0% | -$1.28M+82.6% | ||
| -$8.73M-137% | $4.45M+91.0% | $4.95M+234% | $1.17M+142% | -$3.69M-650% | ||
| $4.55M-37.1% | $1.38M+166% | $0— | $681K— | $7.23M+75.8% | ||
| $12K+180% | -$1K— | $0-100% | $15K+350% | -$15K— | ||
| -$168K-139% | —— | —— | $72K+138% | $435K+680% | ||
| -$62.24M-50.4% | -$43.3M-57.0% | -$47.8M-175% | -$47.92M-211% | -$41.38M-23.1% | ||
| $0-100% | $20K-95.5% | $26K— | $36K— | $851K+1,170% | ||
| $152.07M+102% | $135.4M+88.6% | $135M+487% | $110.35M— | $75.47M— | ||
| $58.31M+121% | -$222.89M-15,531% | —— | —— | -$272.63M-406,815% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $1.01M+75.7% | $5.64M+369% | $1.53M— | $892K— | $575K-96.1% | ||
| $1.7M-99.3% | $216.68M+652% | $11.59M+2,620% | $892K-99.5% | $244.25M+1,436% | ||
| -$2.23M+96.8% | -$49.52M-24,413% | —— | —— | -$69.76M-293% | ||
| $640K-8.3% | $679K+243% | $709K— | $709K— | $698K— | ||
| $1.07M-57.7% | $1.63M-26.2% | $1.74M-30.3% | $2.62M+340% | $2.53M— | ||
| $686K+145% | $3.75M— | $242K-96.0% | $42K-99.1% | $280K-92.6% | ||
| -$168K-139% | —— | —— | $72K+138% | $435K+680% | ||
| -$8.73M-137% | $4.45M+91.0% | $4.95M— | $1.17M— | -$3.69M-19.3% | ||
| $4.55M-37.1% | $1.38M+166% | $0— | $681K— | $7.23M+75.8% | ||
| $206K-0.5% | $211K+66.1% | $211K— | $208K— | $207K— | ||
| $129K+15.2% | $124K+13.8% | $120K+233% | $117K-19.9% | $112K-21.1% | ||
| $12K+180% | -$1K— | $0-100% | $15K+350% | -$15K— | ||
| $152.07M+102% | $135.4M+88.6% | $135M+487% | $110.35M— | $75.47M— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $0-100% | $206.34M— | —— | —— | $234M— | ||
| $0-100% | $4.69M— | —— | —— | $9.39M— | ||
| $687K+139% | —— | $291K+48.5% | —— | $287K+17.1% | ||
| -$168K-139% | —— | —— | $72K+138% | $435K+680% | ||
| —— | $212.5K+18.4% | $212.5K+18.4% | $212.5K+18.4% | $212.5K+18.4% | ||
| -$62.24M-47.4% | -$43.32M-54.6% | -$47.83M-176% | -$47.95M-212% | -$42.23M-25.4% | ||
| -$62.24M-47.4% | -$43.32M-54.6% | -$47.83M-176% | -$47.95M-212% | -$42.23M-25.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Disc Medicine generate?
- Disc Medicine (IRON) generated -$201.3M in operating cash flow over the trailing twelve months.
- What is Disc Medicine's free cash flow?
- After $82.0K of capital expenditures, Disc Medicine's free cash flow was -$201.3M over the trailing twelve months, down 95.5% year over year.
- Where does Disc Medicine's cash flow data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.